Picture of Trevena logo

TRVN — Trevena News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Trevena Reports Positive Topline Olinvyk Cognitive Function Data

July 28 (Reuters) - Trevena Inc  TRVN.O :
    * TREVENA ANNOUNCES POSITIVE TOPLINE OLINVYK COGNITIVE
FUNCTION
DATA AND PROVIDES GENERAL BUSINESS UPDATE
    * TREVENA INC - OLINVYK DEMONSTRATED STATISTICALLY
SIGNIFICANT
REDUCED IMPACT ON NEUROCOGNITIVE FUNCTIONING VERSUS IV MORPHINE
ON PRIMARY ENDPOINT
    * TREVENA INC - NOVEL S1P RECEPTOR MODULATOR TRV045 FOR
DIABETIC
NEUROPATHIC PAIN ON TRACK FOR COMPLETION OF PHASE 1 IN 2H 2022
    * TREVENA INC - STRATEGIC ALLOCATION OF RESOURCES AND COST
REDUCTIONS REINFORCE KEY FOCUS AREAS AND EXTENDS CASH RUNWAY TO
MID-2023

Source text for Eikon:  ID:nGNX4ly6nv 
Further company coverage:  TRVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Trevena

See all news